VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,376 | -65.9% | 147,073 | -10.6% | 0.01% | -64.7% |
| Q2 2023 | $4,033 | -1.6% | 164,483 | -6.6% | 0.02% | -5.6% |
| Q1 2023 | $4,099 | +48.5% | 176,196 | +61.5% | 0.02% | +28.6% |
| Q4 2022 | $2,760 | -99.9% | 109,093 | -45.3% | 0.01% | -33.3% |
| Q3 2022 | $3,843,000 | +5.3% | 199,417 | +39.2% | 0.02% | +10.5% |
| Q2 2022 | $3,648,000 | +1751.8% | 143,249 | +1756.0% | 0.02% | +1800.0% |
| Q1 2022 | $197,000 | -1.5% | 7,718 | +65.8% | 0.00% | 0.0% |
| Q3 2021 | $200,000 | – | 4,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |